News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
395,097 Results
Type
Article (26598)
Company Profile (60)
Press Release (368437)
Multimedia
Podcasts (35)
Webinars (7)
Section
Business (104698)
Career Advice (487)
Deals (16954)
Drug Delivery (54)
Drug Development (47885)
Employer Resources (48)
FDA (12389)
Job Trends (8503)
News (187012)
Policy (19705)
Tag
2027 Biotech Bay Standard (1)
2027 Pharm Country Standard (1)
Academia (1762)
Accelerated approval (17)
Adcomms (12)
Allergies (110)
Alliances (26879)
ALS (98)
Alzheimer's disease (977)
Antibody-drug conjugate (ADC) (163)
Approvals (12710)
Artificial intelligence (305)
Autoimmune disease (90)
Automation (8)
Bankruptcy (142)
Best Places to Work (6899)
BIOSECURE Act (5)
Biosimilars (74)
Biotechnology (40)
Bladder cancer (124)
Brain cancer (36)
Breast cancer (417)
Cancer (3079)
Cardiovascular disease (266)
Career advice (445)
Career pathing (15)
CAR-T (134)
CDC (26)
Celiac Disease (2)
Cell therapy (366)
Cervical cancer (26)
Clinical research (43034)
Collaboration (852)
Compensation (271)
Complete response letters (18)
COVID-19 (1569)
CRISPR (35)
C-suite (486)
Cystic fibrosis (59)
Data (4228)
Decentralized trials (2)
Denatured (20)
Depression (95)
Diabetes (317)
Diagnostics (3737)
Digital health (28)
Diversity (8)
Diversity, equity & inclusion (14)
Drug discovery (95)
Drug pricing (96)
Drug shortages (24)
Duchenne muscular dystrophy (125)
Earnings (38815)
Editorial (28)
Employer branding (6)
Employer resources (47)
Events (54277)
Executive appointments (586)
FDA (14672)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (5)
Frontotemporal dementia (10)
Funding (754)
Gene editing (76)
Generative AI (20)
Gene therapy (267)
GLP-1 (550)
Government (3174)
Grass and pollen (4)
Guidances (232)
Healthcare (12235)
HIV (38)
Huntington's disease (21)
IgA nephropathy (50)
Immunology and inflammation (84)
Immuno-oncology (27)
Indications (67)
Infectious disease (1701)
Inflammatory bowel disease (110)
Inflation Reduction Act (7)
Influenza (52)
Intellectual property (118)
Interviews (50)
IPO (7108)
IRA (23)
Job creations (1854)
Job search strategy (399)
JPM (20)
Kidney cancer (10)
Labor market (36)
Layoffs (203)
Leadership (12)
Legal (3684)
Liver cancer (67)
Longevity (7)
Lung cancer (482)
Lymphoma (251)
Machine learning (16)
Management (17)
Manufacturing (292)
MASH (106)
Medical device (13301)
Medtech (13346)
Mergers & acquisitions (10359)
Metabolic disorders (758)
Multiple sclerosis (96)
NASH (11)
Neurodegenerative disease (162)
Neuropsychiatric disorders (42)
Neuroscience (1700)
NextGen: Class of 2026 (3954)
Non-profit (2841)
Now hiring (33)
Obesity (316)
Opinion (106)
Ovarian cancer (119)
Pain (140)
Pancreatic cancer (140)
Parkinson's disease (166)
Partnered (18)
Patents (225)
Patient recruitment (349)
Peanut (42)
People (35679)
Pharmaceutical (15)
Pharmacy benefit managers (16)
Phase 1 (12360)
Phase 2 (18604)
Phase 3 (15311)
Pipeline (3047)
Policy (137)
Postmarket research (1676)
Preclinical (3812)
Press Release (18)
Prostate cancer (178)
Psychedelics (27)
Radiopharmaceuticals (178)
Rare diseases (437)
Real estate (2873)
Recruiting (18)
Regulatory (15831)
Reports (18)
Research institute (1655)
Resumes & cover letters (53)
Rett syndrome (16)
RNA editing (6)
RSV (39)
Schizophrenia (113)
Series A (117)
Series B (94)
Service/supplier (2)
Sickle cell disease (46)
Special edition (6)
Spinal muscular atrophy (105)
Sponsored (16)
Startups (2136)
Stomach cancer (12)
Supply chain (60)
Tariffs (30)
The Weekly (15)
Vaccines (511)
Venture capital (27)
Weight loss (215)
Women's health (54)
Worklife (4)
Date
Last 7 days (305)
Last 30 days (1107)
Last 365 days (16230)
2026 (1481)
2025 (16582)
2024 (19922)
2023 (22830)
2022 (30759)
2021 (33062)
2020 (32279)
2019 (28493)
2018 (21857)
2017 (18978)
2016 (18165)
2015 (21263)
2014 (16082)
2013 (13289)
2012 (14390)
2011 (14676)
2010 (13238)
Location
Africa (372)
Alabama (30)
Alaska (2)
Arizona (174)
Arkansas (10)
Asia (25561)
Australia (4047)
California (5591)
Canada (1905)
China (785)
Colorado (287)
Connecticut (285)
Delaware (249)
Europe (50022)
Florida (953)
Georgia (226)
Hawaii (1)
Idaho (35)
Illinois (580)
India (32)
Indiana (376)
Iowa (11)
Japan (315)
Kansas (90)
Kentucky (19)
Louisiana (18)
Maine (28)
Maryland (893)
Massachusetts (3742)
Michigan (149)
Minnesota (443)
Mississippi (5)
Missouri (78)
Montana (20)
Nebraska (21)
Nevada (66)
New Hampshire (73)
New Jersey (1944)
New Mexico (10)
New York (1564)
North Carolina (810)
North Dakota (4)
Northern California (2655)
Ohio (213)
Oklahoma (8)
Oregon (28)
Pennsylvania (1348)
Puerto Rico (11)
Rhode Island (35)
South America (529)
South Carolina (59)
Southern California (2242)
Tennessee (124)
Texas (1019)
United States (21671)
Utah (194)
Virginia (141)
Washington D.C. (52)
Washington State (385)
West Virginia (4)
Wisconsin (71)
Wyoming (1)
395,097 Results for "clarify medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tevogen Clarifies Reported Financials, Highlighting Strong Capital Efficiency and Low Cash Burn
November 3, 2025
·
4 min read
Press Releases
Sarepta Therapeutics Provides Clarifying Statement on ELEVIDYS
July 28, 2025
·
8 min read
Press Releases
Revive Therapeutics Clarifies Completion of Key Nerve Agent Countermeasure Study
July 9, 2025
·
3 min read
Press Releases
Essa Pharma Inc. Clarifies Nasdaq Due Bill Trading for Previously Announced Cash Distribution
August 26, 2025
·
9 min read
Government
FDA’s Orphan Drug Director Out Amid IRA Exemption Rollout
An unnamed source clarified that Sandra Retzky has not been fired from the FDA, but it remains unclear where she was reassigned.
October 16, 2025
·
2 min read
·
Tristan Manalac
Press Releases
GoPath Diagnostics Announces Launch of DiabetesNow: A Genetic Test Panel Designed to Clarify Diabetes Diagnosis
June 20, 2025
·
2 min read
Drug pricing
Novo, Lilly Shares Drop as Trump Promises $150 Ozempic
CMS Administrator Mehmet Oz clarified that a deal has not yet been sealed with the manufacturer of semaglutide, Novo Nordisk, or any other GLP-1 drugmaker.
October 17, 2025
·
3 min read
·
Annalee Armstrong
Policy
American Aires Clarifies Corporate Update Press Release
American Aires Inc. (CSE: WIFI) (OTCQB: AAIRF) (“Aires” or the “Company”), a pioneer in innovative technology designed to safeguard against electromagnetic radiation and enhance human well-being, issues this news release in order to clarify certain financial disclosure contained in its news release dated June 18, 2024 (the “June 18th Press Release”).
June 28, 2024
·
6 min read
Press Releases
Medical-imaging company Imagion Biosystems Lodges IND with FDA for Phase 2 Trial of MagSense® HER2 targeted imaging agent
February 4, 2026
·
2 min read
Tariffs
Trump Delays Pharma Tariffs Yet Again
President Donald Trump last week announced that 100% pharma tariffs would come Oct. 1, but a White House official has clarified that that’s when the government will “begin preparing” the levies.
October 2, 2025
·
2 min read
·
Tristan Manalac
1 of 39,510
Next
